Welcome to our dedicated page for WGRX news (Ticker: WGRX), a resource for investors and traders seeking the latest updates and insights on WGRX stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect WGRX's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of WGRX's position in the market.
Wellgistics Health has announced the pricing of its Initial Public Offering (IPO) of 888,889 ordinary shares at $4.50 per share, aiming to raise gross proceeds of $4.0 million. The company's shares have been approved for listing on the Nasdaq Capital Market under the ticker symbol WGRX, with trading expected to commence on February 21, 2025.
The offering, conducted on a firm commitment basis, is expected to close around February 24, 2025. Craft Capital Management and D. Boral Capital are serving as underwriters. The company plans to use the net proceeds for general corporate purposes, including working capital, marketing initiatives, and capital expenditures. The IPO aims to increase capitalization, financial flexibility, marketplace visibility, and create a public market for Common Stock.
FAQ
What is the current stock price of WGRX (WGRX)?
